pyrrolidine dithiocarbamate has been researched along with Becker Muscular Dystrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berge, J; Bledsoe, C; Carlson, CG; Gatti, F; Lavin, J; Millman, G; Palmeiri, B; Rutter, J; Siegel, AL; Turin, E; Winders, WT | 1 |
Carlson, CG; Samadi, A; Siegel, A | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Becker Muscular Dystrophy
Article | Year |
---|---|
Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse.
Topics: Animals; Antioxidants; Cholagogues and Choleretics; Disease Models, Animal; Female; Male; Mice; Mice, Inbred mdx; Muscle Strength; Muscle Stretching Exercises; Muscle Tonus; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; Pyrrolidines; Recovery of Function; Thiocarbamates; Transcription Factor RelA; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Signaling; Cell Survival; Cytosol; Disease Models, Animal; Drug Administration Schedule; Female; Gadolinium; I-kappa B Proteins; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrrolidines; Sarcolemma; Thiocarbamates | 2005 |